2022
DOI: 10.1080/17441692.2022.2049842
|View full text |Cite
|
Sign up to set email alerts
|

University patenting and licensing practices in the United Kingdom during the first year of the COVID-19 pandemic

Help me understand this report
View preprint versions

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1

Citation Types

0
2
0

Year Published

2022
2022
2024
2024

Publication Types

Select...
4
1

Relationship

0
5

Authors

Journals

citations
Cited by 5 publications
(3 citation statements)
references
References 15 publications
0
2
0
Order By: Relevance
“…Various international organizations and leaders have stressed the importance of fair vaccine distribution. The WHO Director-General, Dr. Tedros Adhanom Ghebreyesus, has been vocal about the necessity of ensuring that vaccines reach every part of the world ( Keestra et al, 2022 ). Recognizing that the virus knows no borders, the global community must unite in the fight against COVID-19, and this starts with fair access to vaccines.…”
Section: Survey Methodologymentioning
confidence: 99%
“…Various international organizations and leaders have stressed the importance of fair vaccine distribution. The WHO Director-General, Dr. Tedros Adhanom Ghebreyesus, has been vocal about the necessity of ensuring that vaccines reach every part of the world ( Keestra et al, 2022 ). Recognizing that the virus knows no borders, the global community must unite in the fight against COVID-19, and this starts with fair access to vaccines.…”
Section: Survey Methodologymentioning
confidence: 99%
“…Furthermore, the social responsibility and sustainable development of university patenting may also be a future research agenda. Especially during public crises, such as the COVID-19 pandemic, it remains to be seen whether the university's rights under the Bayh-Dole Act to patents derived from government funding should be limited [22], [96].…”
Section: F Future Agendamentioning
confidence: 99%
“…Especially regarding crises of a global scale, like the COVID-19 pandemic, it may be appropriate to tailor IP policies in terms of public health requirements 111 . In this view, various tools have been developed, such as patent pools or equitable licensing strategies of universities that are applicable to the bottom-up assembly of viruses [112][113][114] . Therefore, the ethical dimension of synthetic virion research involves the assessment of benefits and risks concerning patenting and licensing strategies.…”
Section: Biosecuritymentioning
confidence: 99%